TCL Archive Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research January 4, 1991
TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive Eight Probable Minority CCOP Awardees Lister; NCI May Award As Many As 12, With 220 Payline June 1, 1990
TCL Archive In Brief: Reauthorization May Be Wrapped Up This Week As House, Senate Work Toward Compromise October 14, 1988
